Jose Mandujano
Pediatric Pulmonology · Frisco, TXNPI 1508817206
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 465 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Among pediatric pulmonology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 465 payments — averaging $22.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Regeneron Healthcare Solutions, Inc.$725
- AbbVie$666
- Sanofi$659
- GSK$654
- Vertex$639
- plus $5K from 27 others
Across 8 payments — averaging $8543.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Octapharma USA, Inc.$40K
- GSK$29K
What the payments were for
- Food & beverage$10,30799%
- Education$1121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 71 | $1,791 |
| Regeneron Healthcare Solutions, Inc. | 21 | $725 |
| AbbVie(2 entities) | 21 | $666 |
| Sanofi | 24 | $659 |
| GSK | 27 | $654 |
| Vertex | 20 | $639 |
| Grifols USA, LLC | 27 | $609 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $562 |
| Covis Pharma GmbH | 29 | $490 |
| Novartis | 22 | $443 |
| CSL Behring | 16 | $426 |
| Amgen(2 entities) | 20 | $404 |
| Genentech USA, Inc. | 18 | $326 |
| Baxter Healthcare | 17 | $286 |
| Philips North America LLC | 13 | $214 |
| Sobi, Inc | 7 | $208 |
| Chiesi USA, Inc. | 25 | $177 |
| Advanced Respiratory, Inc | 10 | $158 |
| Boehringer Ingelheim | 11 | $154 |
| Teva Pharmaceuticals USA, Inc. | 7 | $131 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $110 |
| Nestle Healthcare Nutrition Inc. | 6 | $104 |
| Pharming Healthcare, Inc. | 4 | $92 |
| Electromed, Inc. | 4 | $74 |
| Octapharma USA, Inc. | 2 | $59 |
| Mylan Specialty L.p. | 3 | $52 |
| Shire North American Group Inc | 3 | $50 |
| Gilead | 2 | $48 |
| Pfizer | 1 | $26 |
| Aytu Biopharma, Inc. | 2 | $25 |
| Alk-abello, Inc | 1 | $21 |
| Kaleo, Inc. | 1 | $20 |
| Vivus LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,419 in reported general payments places this provider in the 90th percentile of 104 pediatric pulmonology providers in Texas.
Other pediatric pulmonology in Frisco
- Carlos MedinaFrisco$9K
- Sarat SusarlaHouston$194K
- Jason FullmerAustin$74K
- Kelly SmithSan Antonio$69K
- Carolyn CannonDallas$55K
- Shailendra DasFort Worth$23K
- Donna Willey-CourandSan Antonio$19K
- Fadel RuizHouston$17K
- Peter HiattHouston$16K
- Steven CopenhaverDallas$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.